Form D · Biotechnology
Hiberna Corp
Boulder, CO · CIK 0001403111
Offering snapshot reported Mar 13, 2009 · SEC filing
- Reported sold
- $100K Offering amount: $1M
- Investors reported
- Not reported Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Not reported As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 13, 2009 | Initial | $100,000 | No comparison | Not reported | SEC filing |
| Jun 11, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- Not reported
- Finders' fees
- Not reported
- Form D file number
- 021-104615
Source: Form D, filed Mar 13, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Kyle Lefkoff | Director |
| Leslie Leinwand | Director |
| Thomas Marr | Director, Executive, Promoter |
| Rex O'neal | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1900 Ninth Str Suite 200
Boulder, CO, 80302
Boulder, CO, 80302